Ruban Mangadu

SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells<b><i>In vitro</i></b>and<b><i>In vivo</i></b>

Martin Uhl, Steffen Aulwurm, Jörg Wischhusen et al. · Cancer Research · 2004 · 410 citations · Full text

Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells

Ivan H. Chan, Renu Jain, Marlowe S. Tessmer et al. · Mucosal Immunology · 2013 · 142 citations · Full text

Cytokine, Mucosal Immunology, T-regulatory Cell +6

A Selective p38α Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis

Satyanarayana Medicherla, Ying Jing, Ruban Mangadu et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 77 citations

Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells

Selvakumar Sukumar, Douglas C. Wilson, Ying Yu et al. · Cancer Research · 2017 · 63 citations

Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.

Satyanarayana Medicherla, Lingyun Li, Ying Jing et al. · PubMed · 2008 · 61 citations

Tumor Biology, Pancreatic Cancer, Tgf-beta Inhibitor +15